Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista de la OFIL
versión On-line ISSN 1699-714Xversión impresa ISSN 1131-9429
Resumen
ARROYO-MONTERROZA, DA et al. Drug-therapy problems associated with total parenteral nutrition detected in pharmaceutical care practice and their economic impact. Rev. OFIL·ILAPHAR [online]. 2021, vol.31, n.4, pp.411-415. Epub 19-Sep-2022. ISSN 1699-714X. https://dx.doi.org/10.4321/s1699-714x20210004000014.
Introduction:
Total parenteral nutrition is the administration of the nutrients that an individual requires intravenously. It is not a method free of complications. The Pharmacist in care area through pharmacotherapeutic monitoring can contribute to the improvement of the nutritional therapy of a patient with Total parenteral nutrition.
Objective:
To detect pharmacotherapy problems associated with total parenteral nutrition through pharmacotherapy follow-up in patients and the savings from pharmaceutical interventions generated in a third level clinic in Barranquilla-Colombia.
Methodology:
It was performed an evaluative study with a quasi-experimental methodological design of ambyespective type, in relation to the time of collection of the data, in 109 patients prescribed with total parenteral nutrition in a third level clinic located in Barranquilla Colombia, in the period between November-December 2018 and January-May 2019.
Results:
A total of 81 drug related problem were detected during study phase, of which 75,31% were dose type and/or inadequate duration. 20 drug related problem became into negative outcome medications, of these, 55% were quantitative ineffectiveness type. 81 interventions were performed, with an acceptance percentage of 93,83% (76), of these accepted interventions, 67 problems were solved, 5 interventions were not accepted and 14 problems could not be solved due to different factors. Regarding the savings generated, the figure of $12.751.595 COP was reached in six months of study development.
Conclusion:
The identification of the patient's profile and the risks associated with nutritional support will help generate an economic impact for the institution and clinician on the patient by having a comprehensive view of the associated pharmacotherapeutic problems.
Palabras clave : Parenteral nutrition total; clinical pharmacy services; patient care management; nutrients; patient care teams.